Delivery Order SPE2DR25D3504-SPE2DR26F7CD2
Award Date 1/7/26
Potential Completion Date 1/8/26
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $12,228.81 to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 17, 2025, with an ultimate completion date of December 18, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,328.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 6, 2025, with an ultimate completion date of December 8, 2025. This non-competitive delivery order represents a small-value transaction issued against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999.00 prime vendor agreement valued through December 2026. The place of performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,328.32 to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 2, 2025, with an ultimate completion date of December 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The order will be fulfilled from the contractor's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,862.55 to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation and will be performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $1,992.15 delivery order to AmerisourceBergen Drug Corp for ACT-O-Vials on December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,283.20 to AmerisourceBergen Drug Corp for ACT-O-VIALS on November 5, 2025, with completion expected by November 6, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, is...
- The Defense Logistics Agency awarded a delivery order valued at $13,283.20 to AmerisourceBergen Drug Corp for ACT-O-VIALS on November 25, 2025, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order was competitively awarded without any set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $6,813.71 to AmerisourceBergen Drug Corp for ACT-O-VIALS, effective January 5, 2026, with completion by January 6, 2026. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order is being fulfilled from the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $7,792.68 to AmerisourceBergen Drug Corp for ACT-O-Vials on December 15, 2025, with completion scheduled for December 16, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major healthcare solutions provider and pharmaceutical distributor, serves...
- The Defense Logistics Agency awarded a delivery order valued at $10,604.05 to AmerisourceBergen Drug Corp on December 11, 2025, for ACT-O-VIALS pharmaceutical products. The contract represents a firm fixed price delivery order with an ultimate completion date of December 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded through open competition. This...